Diagnostic delay, quality of life and patient satisfaction among women diagnosed with endometrial or ovarian cancer: A nationwide Danish study

Quality of Life Research

Volumn 21, Issue 9, 2012, Pages 1519-1525

  Robinson, Kirstine M ^a   Christensen, Karl Bang ^a   Ottesen, Bent ^b   Krasnik, Allan ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Delayed diagnosis; Gynecology; Neoplasms; Patient satisfaction; Quality of life

Indexed keywords

AGED; ARTICLE; CONFIDENCE INTERVAL; DELAYED DIAGNOSIS; DENMARK; ENDOMETRIUM TUMOR; FACTUAL DATABASE; FEMALE; GYNECOLOGY; HEALTH CARE SURVEY; HUMAN; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUALITY OF LIFE; WOMEN'S HEALTH;

AGED; CONFIDENCE INTERVALS; DATABASES, FACTUAL; DELAYED DIAGNOSIS; DENMARK; ENDOMETRIAL NEOPLASMS; FEMALE; GYNECOLOGY; HEALTH CARE SURVEYS; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PATIENT SATISFACTION; PSYCHOMETRICS; QUALITY OF LIFE; WOMEN'S HEALTH;

EID: 84867997590     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-011-0077-3     Document Type: Article

References (23)

1. Blumenthal, D. (1996). Part 1: Quality of care - What is it? New England Journal of Medicine, 335, 891-894. (Pubitemid 26304076)
2. Neal, R. D. (2009). Do diagnostic delays in cancer matter? Brit. J. Cancer, 101(Suppl 2), S9-S12.
3. Richards, M. A., Westcombe, A. M., Love, S. B., Littlejohns, P., & Ramirez, A. J. (1999). Influence of delay on survival in patients with breast cancer: A systematic review. Lancet, 353, 1119-1126. (Pubitemid 29155203)
4. Neal, R. D., Allgar, V. L., Ali, N., Leese, B., Heywood, P., Proctor, G., et al. (2007). Stage, survival and delays in lung, colorectal, prostate and ovarian cancer: comparison between diagnostic routes. British Journal of General Practice, 57, 212-219. (Pubitemid 46358938)
5. Crawford, S. C., Davis, J. A., Siddiqui, N. A., de Caestecker, L., Gillis, C. R., Hole, D., et al. (2002). The waiting time paradox: Population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ, 325, 196. (Pubitemid 34827892)
6. Rupassara, K. S., Ponnusamy, S., Withanage, N., & Milewski, P. J. (2006). A paradox explained? Patients with delayed diagnosis of symptomatic colorectal cancer have good prognosis. Colorectal Dis, 8, 423-429. (Pubitemid 43676658)
7. Schwartz, C. E., & Sprangers, M. A. (2002). An introduction to quality of life assessment in oncology: The value of measuring patient-reported outcomes. American Journal of Managed Care, 8, S550-S559. (Pubitemid 36096927)
8. Cella, D. F., & Tulsky, D. S. (1990). Measuring quality of life today: Methodological aspects. Oncology (Williston Park), 4, 29-38.
9. Chow, A., Mayer, E. K., Darzi, A. W., & Athanasiou, T. (2009). Patient-reported outcome measures: The importance of patient satisfaction in surgery. Surgery, 146, 435-443.
10. Coates, A., Porzsolt, F., & Osoba, D. (1997). Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. European Journal of Cancer, 33, 1025-1030. (Pubitemid 27310776)
11. Maisey, N. R., Norman, A., Watson, M., Allen, M. J., Hill, M. E., & Cunningham, D. (2002). Baseline quality of life predicts survival in patients with advanced colorectal cancer. European Journal of Cancer, 38, 1351-1357. (Pubitemid 34686846)
12. Gotay, C. C., Kawamoto, C. T., Bottomley, A., & Efficace, F. (2008). The prognostic significance of patient-reported outcomes in cancer clinical trials. Journal of Clinical Oncology, 26, 1355-1363.
13. Robinson, K. M., Ottesen, B., Christensen, K. B., & Krasnik, A. (2009). Diagnostic delay experienced among gynecological cancer patients: A nationwide survey in Denmark. Acta Obstetricia et Gynecologica Scandinavica, 88, 685-692.
14. The Danish Cancer Society. (2006) A cancer patients world.
15. Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365-376. (Pubitemid 23073154)
16. Benedet, J. L., Bender, H., Jones, H., I. I. I., Ngan, H. Y., & Pecorelli, S. (2000). FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on gynecologic oncology. International Journal of Gynaecology & Obstetrics, 70, 209-262.
17. Thind, A., Hoq, L., Diamant, A., & Maly, R. C. (2010). Satisfaction with care among low-income women with breast cancer. Journal of Womens Health (Larchmt), 19, 77-86.
18. Montazeri, A. (2009). Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health and Quality of Life Outcomes, 7, 102.
19. Greimel, E., Daghofer, F., & Petru, E. (2011). Prospective assessment of quality of life in long-term ovarian cancer survivors. International Journal of Cancer, 128, 3005-3011.
20. Carey, M. S., Bacon, M., Tu, D., Butler, L., Bezjak, A.,&Stuart, G. C. (2008). The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer. Gynecologic Oncology, 108, 100-105. (Pubitemid 350299429)
21. Gupta, D., Grutsch, J. F., & Lis, C. G. (2008). Patient satisfaction with quality of life as a prognostic indicator in ovarian cancer patients treated in an integrative treatment setting. Journal of the Society for Integrative Oncology, 6, 98-104.
22. Bezjak, A., Tu, D., Bacon, M., Osoba, D., Zee, B., Stuart, G., et al. (2004). Quality of life in ovarian cancer patients: Comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study. Journal of Clinical Oncology, 22, 4595-4603. (Pubitemid 41185127)
23. Groenvold, M., Klee, M. C., Sprangers, M. A., & Aaronson, N. K. (1997). Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. Journal of Clinical Epidemiology, 50, 441-450. (Pubitemid 27223274)